BECLOMETHASONE DIPROPIONATE; FORMOTEROL FUMARATE; GLYCOPYRROLATE | N219622 | CHIESI FARMACEUTICI SPA
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 10159645Newly listed — daily FDA feed, not yet in monthly Orange Book edition | Dec 23, 2030 | — | — | Yes | — | |
| 10617638Newly listed — daily FDA feed, not yet in monthly Orange Book edition | Dec 23, 2034 | — | — | Yes | — | |
| 10806701Newly listed — daily FDA feed, not yet in monthly Orange Book edition | Dec 23, 2030 | — | — | Yes | — | — |
| 11389401Newly listed — daily FDA feed, not yet in monthly Orange Book edition | Dec 23, 2030 | — | — | Yes | — | — |
| 11590074Newly listed — daily FDA feed, not yet in monthly Orange Book edition | Dec 23, 2030 | — | — | — | — | |
| 12357568Newly listed — daily FDA feed, not yet in monthly Orange Book edition | Dec 23, 2030 | — | — | Yes | — |
| Code | Date | Status |
|---|---|---|
| NPNewly listed — daily FDA feed, not yet in monthly Orange Book edition | May 14, 2029 | Active |
TRIMBOW (beclomethasone dipropionate; formoterol fumarate; glycopyrrolate) acquired New Chemical Entity exclusivity expiring May 2029.
New: TRIMBOW (BECLOMETHASONE DIPROPIONATE; FORMOTEROL FUMARATE; GLYCOPYRROLATE) — exclusivity NP exp 05/14/2029
Chiesi's supplemental application (NDA 219622-002) for Trimbow (beclomethasone dipropionate/formoterol fumarate/glycopyrrolate) gained new product exclusivity with an expiration date of May 2029.
New: TRIMBOW (BECLOMETHASONE DIPROPIONATE; FORMOTEROL FUMARATE; GLYCOPYRROLATE) — exclusivity NP exp 05/14/2029